Aju IB Investment

Founded in 1974, Aju IB Investment is a venture capital firm headquartered in Seoul, South Korea, with additional offices in Boston and San Francisco. The company specializes in investing in small to medium-sized startups across various sectors, including information technology, biotechnology, life science, environment, healthcare, and technology.

Yoon Chang-soo

General Manager

Daeseok Jung

Director, Investment Strategy Division

Jeong Moo-il

Team manager

151 past transactions

Healing Paper

Series C in 2025
Healing Paper leverages information technology to enhance accessibility to medical services, reduce costs, and facilitate balanced communication between healthcare professionals and non-experts.

Gangnam Unni

Series C in 2025
Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and a plastic surgery hospital. The difficulty of navigating the process of seeking medical treatment and choosing a hospital continues to persist. Kangnam Unni recognizes the need for change and firmly believes that a combination of transparent medical information and an IT platform can foster a consumer-oriented medical service market. Their ultimate goal is to challenge negative perceptions surrounding plastic surgery and spearhead a significant transformation in the beauty and medical service industries. The Gangnam Unni team is dedicated to innovation, fueled by an unwavering desire to provide exceptional beauty and medical services. With the aim of assisting individuals in selecting a suitable hospital, they have amassed an impressive database of one million user reviews. Additionally, their efforts to promote transparency in medical information have garnered the support of 3,000 subscribers through Gangnam Sister. Furthermore, their mobile application has facilitated hospital consultations for a staggering 3.8 million individuals, resulting in 1.6 million successful cases. As the team continuously clarifies its mission and forges ahead with determination, its collective strength and resolve only grow stronger. Kangnam Unni remains committed to revolutionizing the healthcare industry, ensuring that individuals receive the highest quality of care and a positive experience throughout their medical journeys.

Selvatico

Seed Round in 2025
Selvatico, based in Seoul, South Korea, is a leading manufacturer of personal care products. It specializes in producing high-quality perfumes, hand creams, liquid soaps, and home fragrances, developed under stringent French standards to maintain traditional craftsmanship. Notably, Selvatico offers a unique niche perfume collection inspired by French impressionist culture, reimagined for modern consumers.

Kovis Technology

Series B in 2024
Kovis Technology specializes in the production of high-precision measurement and inspection equipment, catering primarily to the global semiconductor and electronics industries. Their product portfolio includes a comprehensive platform equipped with tools to assess mass, thermal properties, warpage, thickness variation, dielectric characteristics, bond strength, and surface profiles. This enables semiconductor manufacturers and research facilities to perform non-destructive evaluations throughout the fabrication process.

PGT

Series D in 2024
PGT is a manufacturing company that develops specialty chemicals designed to be used as industrial raw materials.

SigzenGuru

Series A in 2024
SigzenGuru is an RF development company that specializes in frequency synthesizers, wideband converters, and communication system business.

BeauBrain Healthcare

Series A in 2024
BeauBrain Healthcare specializes in early intervention for Alzheimer's disease. It offers a predictive analysis platform that identifies disease-specific biomarkers like Amyloid Beta and Tau, enabling early detection. Additionally, it provides a personalized cognitive training platform (DTx) to help manage the condition proactively.

Hurotics

Seed Round in 2024
Hurotics is a technology company specializing in wearable robotic devices for individuals with gait disorders. Their flagship product, the 'H-Flex', is a modular, AI-driven exosuit that provides personalized support, aiding users in overcoming physical limitations and enhancing muscle strength.

DEEPX

Series C in 2024
DEEPX is a Korean software and hardware company specializing in artificial intelligence solutions. It develops next-generation neural networks that enhance AI silicon for deep learning applications. By focusing on the core properties of neural networks, DEEPX maximizes memory bandwidth, enabling edge devices to efficiently run advanced AI models. This technology allows companies to implement power-efficient on-device AI, promoting sustainable operations in various applications.

Hutom

Series C in 2024
Hutom is a surgical service platform that leverages digital innovation to enhance the diagnosis and management of surgical procedures. The company specializes in robotics and laparoscopic surgery, offering an interactive platform that includes analytical diagnosis tailored to individual patient needs. Hutom's technology encompasses surgical video processing, recognition, analysis, and predictive capabilities, allowing for a simulated examination of surgeries. Additionally, it provides 3D anatomical images and AI-based surgical analysis reports, which aid medical professionals in efficiently managing patient complications and improving surgical methods. Through its comprehensive data platform, Hutom aims to positively impact the quality of surgical care.

DEEPX

Funding Round in 2024
DEEPX is a Korean software and hardware company specializing in artificial intelligence solutions. It develops next-generation neural networks that enhance AI silicon for deep learning applications. By focusing on the core properties of neural networks, DEEPX maximizes memory bandwidth, enabling edge devices to efficiently run advanced AI models. This technology allows companies to implement power-efficient on-device AI, promoting sustainable operations in various applications.

Home Check

Series A in 2024
Home Check offers comprehensive property management services for residential buildings. Their platform streamlines efficiency in the real estate industry by providing services such as apartment inspections, safety diagnoses, seismic safety checks, and construction evaluations for individual homes to multi-unit complexes.

Kanaph Therapeutics

Series C in 2023
Kanaph Therapeutics is a biotechnology company focused on developing next-generation therapeutics for oncology and autoimmune diseases. Founded in 2019 and headquartered in Seoul, South Korea, the company engages in drug development activities ranging from discovery to early-stage clinical trials. Its therapeutic platform includes bi-specific antibodies, Fc-fusions, and small molecules. In oncology, Kanaph Therapeutics develops drugs with enhanced immuno-stimulatory activity in the tumor microenvironment for efficient tumor eradication. For autoimmune diseases, the company's pipeline features bispecific Fc-fusions that inhibit the alternative complement pathway, angiogenesis, and downstream complement activation. The company serves both Korea and the United States.

KRISTIN

Series A in 2023
KRISTIN is a supplier of flat, sneakers, and boots.

CareMedi

Series B in 2023
CareMedi is a healthcare company specializing in the development of innovative medical devices, particularly a wearable drug pump designed to enhance the quality of life for individuals with diabetes. The company's platform offers a range of healthcare products, including medical equipment, nebulizers, aspirators, and massagers. By enabling consumers to conveniently order these products from home, CareMedi aims to improve overall lifestyle and health outcomes for its users.

Primemas

Seed Round in 2023
Primemas is a semiconductor startup headquartered in New York, with a research and development center located in Seoul. The company specializes in innovative Hub Chiplet System on Chip (SoC) modules aimed at the growing chiplet industry. Its Hub Chiplets, known as "Hublets," utilize high-bandwidth, low-latency direct-to-direct (D2D) interfaces, facilitating efficient infrastructure sharing with custom partner dies. This design enables Primemas Hublets to serve a diverse range of markets, including artificial intelligence, cryptocurrency, and data analytics. By leveraging these advanced technologies, Primemas significantly reduces the time and cost associated with designing and manufacturing custom SoCs, achieving efficiencies that can cut these processes by up to ten times.

True Balance

Debt Financing in 2023
True Balance is a digital wallet platform serving over 70 million users in India. It offers utility bill payments, loan recharge, insurance, and other financial products, targeting unbanked individuals for their daily monetary needs.

Enflow

Series A in 2023
Enflow is a technology company focused on developing next-generation, all-solid-state batteries. Its mission is to mitigate environmental damage caused by fossil fuel consumption by creating more efficient and sustainable energy storage solutions for a greener future.

Returnit

Seed Round in 2023
RETURNIT is a service that replaces single-use containers with reusable containers used for food delivery.

COM2US ROCA

Seed Round in 2023
COM2US ROCA is a developer of a location-based social networking game that allow users to meet new people in neighborhood.

Live Anywhere

Series A in 2023
Live Anywhere is a global short-term rental platform that facilitates bookings for over 10,000 fully furnished houses across 165 cities worldwide. The company specializes in offering direct reservations for mid- to long-term stays, providing customers with convenient and affordable accommodation options for durations ranging from weeks to months.

Dreammark One

Venture Round in 2023
Dreammark One is a data center services company that provides cloud, infrastructure and security solutions.

BRLab

Venture Round in 2023
BRLab specializes in developing advanced sleep analysis and enhancement solutions. The company utilizes a unique, patented sleep-enhancing technology validated by scientific research, along with highly reliable AI-powered algorithms. BRLab's platform is designed to monitor users' sleep patterns and provide digital healthcare tools that improve sleep quality without requiring lifestyle changes.

M3SEN

Series A in 2023
M3SEN is an artificial intelligence company specializing in 3D image reconstruction and lidar technology services. It develops advanced sensing and deep learning solutions aimed at enhancing productivity in the pig farming industry. By utilizing AI processing, M3SEN monitors adult female pigs in real-time, analyzing extensive data collected from multiple cameras simultaneously. This technology helps farmers address critical issues such as delivery complications, stillbirths, and suffocation risks associated with fetal membranes, ultimately contributing to improved animal welfare and operational efficiency in livestock management.

Wavebridge

Series B in 2022
Founded in November 2018, Wavebridge is a leading digital asset company specializing in institutional investments. It offers comprehensive solutions leveraging advanced data processing and AI technology, focusing on both traditional and crypto finance.

LBox

Series B in 2022
LBox develops a digital platform that simplifies legal information lookup. Legal experts use this search engine to find case law, legal papers, and publications for case-related research.

DOWHAT

Seed Round in 2022
DOWHAT is a smart hotel integration platform.

Onconic Therapeutics

Series B in 2022
Onconic Therapeutics focuses on researching and developing innovative treatments for gastrointestinal diseases and cancers, addressing significant unmet medical needs.

JNPMEDI

Series A in 2022
JNPMEDI develops a medical data platform for conducting clinical research and managing trials. It specializes in digital transformation tools for regulatory authorities, pharmaceuticals, and clinical research organizations.

Laundrygo

Series C in 2022
Laundrygo is an on-demand laundry service that offers subscription-based laundry cleaning solutions. The company focuses on delivering a convenient and efficient alternative to traditional laundry services by ensuring that customers receive their cleaned laundry within one day. By providing this rapid turnaround at a lower cost than conventional laundry shops, Laundrygo aims to enhance the customer experience and eliminate the hassle often associated with laundry tasks.

Genkore

Series A in 2022
GenKOre is a biotech company focused on advancing gene therapy through innovative genetic editing technologies. The company develops a healthcare platform aimed at addressing medical emergencies by providing educational programs on genome editing, therapeutic approaches, and plant biotechnology. Through its initiatives, GenKOre seeks to enhance the genetic health of patients and improve overall welfare in the healthcare sector by offering comprehensive information and resources related to genetic advancements.

Boram

Seed Round in 2022
Boram provides postnatal care services to support mothers after childbirth, offering postnatal retreats and virtual postpartum coaches, lactation and feeding assistance, and basic baby care to help mothers care for themselves and their babies.

ICT Compliance

Seed Round in 2022
ICT Compliance is a tech company specializing in authentication solutions.

Encell

Series C in 2022
ENCell is a biopharmaceutical company focused on developing and manufacturing innovative therapies for rare and incurable muscle diseases, including Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia. The company specializes in contract development and manufacturing services (CDMO) in the biopharmaceutical sector, alongside its efforts in cell and gene therapy new drug development. ENCell aims to address significant unmet medical needs within this specialized field, leveraging its expertise to advance therapeutic solutions for patients affected by these challenging conditions.

Armored Fresh

Series A in 2022
Armored Fresh is a food company producing plant-based cheese from almond milk. Its mission is to create a sustainable world by offering dairy-like cheese alternatives that are healthier for people and animals.

Mxt Biotech

Series A in 2022
Mxt Biotech is a biotechnology company developing microfluidic platforms for cell engineering and immunotherapies. The company focuses on non-viral intracellular delivery, offering automated microfluidic-based systems to introduce genes and nucleic acids into cells, enabling gene editing and the advancement of cell therapies. Its technology supports scalable, controlled delivery processes to enhance cell viability and therapeutic efficacy, with applications in research and clinical development of immune and other cell-based therapies.

Wave

Seed Round in 2022
Wave is a food tech company that offers robot-based kitchen operation services for the food service industry.

Kimcaddie

Series A in 2022
Kimcaddie is a company based in Seoul, South Korea, founded in 2019. It operates an online platform that serves as a comprehensive resource for golf enthusiasts, offering information about nearby golf stores. Users can find details on store locations, read reviews, and learn about available facilities. Additionally, Kimcaddie provides a screen golf platform, enhancing the overall golf experience by integrating various aspects of the sport. The company aims to connect golfers with relevant resources and improve access to golf-related services.

Live Anywhere

Seed Round in 2022
Live Anywhere is a global short-term rental platform that facilitates bookings for over 10,000 fully furnished houses across 165 cities worldwide. The company specializes in offering direct reservations for mid- to long-term stays, providing customers with convenient and affordable accommodation options for durations ranging from weeks to months.

Fine One

Seed Round in 2022
Fine One is a manufacturer and supplier of vacuum components and process equipment parts for OLED and semiconductor manufacturing. The company develops OLED evaporator parts and display process components to support the production of display technologies. It offers application parts for OLED and semiconductor process equipment, enabling customers to use OLED evaporator materials and related parts in their manufacturing processes.

Daan Biotherapeutics

Seed Round in 2022
DAAN Biotherapeutics is a biopharmaceutical company focused on developing innovative treatments for cancer patients. The company specializes in research and development in the field of cancer therapies, employing a range of approaches such as cell therapies, antibodies, and small molecule inhibitors. DAAN Biotherapeutics is particularly dedicated to immune-oncology, utilizing anticancer immune cell therapies, including natural killer (NK) cells and T cell receptors. Through its independent research infrastructure, the company conducts clinical trials to explore various treatment strategies, aiming to create effective new drugs, particularly for lung cancer. By providing healthcare providers with advanced therapeutic options, DAAN Biotherapeutics seeks to improve outcomes for cancer patients.

bHaptics

Series B in 2022
bHaptics specializes in full-body haptic technology, offering a high-end vest with 40 feedback points that provides lag-free wireless touch sensations. Compatible with various platforms and games, it enhances virtual reality experiences.

Value Link Oil

Series A in 2022
Value Link Oil is a platform service company that provides transportation connection, data-based management, and consulting services.

KRISTIN

Seed Round in 2022
KRISTIN is a supplier of flat, sneakers, and boots.

iN Therapeutics

Series B in 2022
iN Therapeutics is a biotechnology company focused on developing novel therapies for patients with intractable neurological disorders. Its drug development platform concentrates on Nav1.7 non-narcotic analgesics, hearing loss treatments, and brain disease therapeutics, aiming to provide pharmaceutical and biotech industries access to innovative central nervous system disease drugs.

Organoid Sciences

Series B in 2022
Organoid Sciences is a biotechnology company founded in 2018 and located in Seongnam-si, South Korea. The company specializes in developing organoid-based therapies using its proprietary Keo cannabinoid technology to address various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, aiming to advance treatment options through innovative approaches.

Willog Co.

Series A in 2022
Willog is an IoT-based logistics intelligence company that provides real-time visibility across the entire supply chain through its proprietary sensor devices and platform. This enables businesses to monitor various data points such as location, temperature, humidity, and shock during transportation, helping them track assets and ensure consistent product quality. Willog’s solution helps identify potential issues in the logistics process in advance and suggests solutions to save time and reduce costs. It is applicable across various industries and empowers customers to make data-driven decisions. • Sensor Devices (Hardware) To meet the needs of various customers and transportation sectors, Willog offers a lineup of monitoring devices tailored to each logistics segment. These devices collect logistics data throughout the transport process and securely transmit it to the monitoring software. • Monitoring Solution (Software) Willog provides software optimized for logistics processes in tandem with its sensor devices. The software intuitively displays logistics condition data such as temperature, humidity, shock, and light levels collected during transport, eliminating the need for time-consuming manual tasks like post-delivery data mapping. Based on the collected data, the system analyzes shipment history to detect potential issues in advance during transportation and storage, helping to predict and minimize loss or cost. Additionally, Willog’s proprietary data analysis methodology, Willog Connected Intelligence, generates specialized analytics reports for each logistics domain—delivering insights beyond basic data logs and alerts.

JNPMEDI

Seed Round in 2022
JNPMEDI develops a medical data platform for conducting clinical research and managing trials. It specializes in digital transformation tools for regulatory authorities, pharmaceuticals, and clinical research organizations.

Victex

Venture Round in 2021
Victex is a manufacturer of dry ice washing systems designed to facilitate the supply of dry ice to various industries. The company operates its own dry ice production plant, ensuring a reliable and localized source of dry ice for its customers. Additionally, Victex maintains a customer support center staffed with professionals who assist in the rapid establishment of its systems across the country. This strategic approach enables Victex to provide businesses with a consistent and secure supply of dry ice, enhancing operational efficiency and reliability.

Happy Moonday

Series A in 2021
Founded in Seoul, South Korea in 2017, Happy Moonday specializes in the manufacture and sale of organic sanitary pads and related products. Its mission is to empower women by providing high-quality, organic healthcare solutions.

Astron Security

Series A in 2021
Astron Security is a cloud security technology company that focuses on providing core technology services to businesses. It has developed a cloud workload security platform that is designed to detect abnormalities and respond automatically. The company's offerings include automated asset management, real-time change recording, precise abnormality detection, host health monitoring, and optimization of firewall policy management. Through its comprehensive three-step defense approach, Astron Security enables IT professionals to effectively manage firewall support for cloud workloads in real-time, enhancing the overall security posture of organizations.

Kukka

Series B in 2021
Kukka, Inc. is a Seoul-based company that specializes in providing a variety of flower-related services, including flower subscription, bouquet delivery, and custom floral design. Established in 2014, Kukka aims to promote the enjoyment of flowers in everyday life, inspired by Finnish culture. Its offerings cater to both individual and corporate clients, featuring corporate event support flowers, promotional flower boxes, and floral decorations. The company also provides same-day delivery and organizes flower art classes, enhancing the floral experience for its customers. Through its retail stores and online platform, Kukka facilitates easy access to fresh flowers and related accessories.

Onuii

Series A in 2021
Onuii is a mobile tutoring platform focused on enhancing personalized digital learning for middle and high school students. The platform allows students to seek assistance with study methods, entrance exam preparation, and career counseling from qualified tutors. By facilitating real-time question-and-answer interactions, Onuii enables students to clarify their doubts effectively while providing private tutors with opportunities to earn additional income. Through its innovative approach, Onuii aims to improve educational outcomes and support students in their academic and career pursuits.

Dot Mill

Seed Round in 2021
Dot Mill is a mixed reality content production company.

Dabeeo

Series B in 2021
Dabeeo Inc. is an AI technology company based in Seoul, South Korea, founded in 2012. Specializing in geospatial data, Dabeeo focuses on creating a digital twin of the Earth by utilizing AI-powered data transformation to digitize spatial information. The company offers a comprehensive mapping technology platform that enables users to manage spatial data effectively. By employing artificial intelligence and deep learning, Dabeeo provides quick access to live maps and locations, allowing for open-source map editing. This innovation enhances the quality of map data available to businesses, improving productivity and convenience across various industries.

Dabeeo

Series B in 2021
Dabeeo Inc. is an AI technology company based in Seoul, South Korea, founded in 2012. Specializing in geospatial data, Dabeeo focuses on creating a digital twin of the Earth by utilizing AI-powered data transformation to digitize spatial information. The company offers a comprehensive mapping technology platform that enables users to manage spatial data effectively. By employing artificial intelligence and deep learning, Dabeeo provides quick access to live maps and locations, allowing for open-source map editing. This innovation enhances the quality of map data available to businesses, improving productivity and convenience across various industries.

Immunobiome

Series B in 2021
Immunobiome is a biotechnology company focused on developing microbiome-based therapeutics aimed at treating challenging diseases, including cancer, autoimmune disorders, allergies, and neurological conditions. By leveraging advanced immunology, bioinformatics, and fundamental microbiome research, the company seeks to create innovative solutions that address conditions often deemed incurable. Its platform specializes in targeted treatments that can help manage intractable immune-related diseases and improve patient outcomes in various health challenges, including organ transplant rejections and inflammation-related issues.

LBox

Series A in 2021
LBox develops a digital platform that simplifies legal information lookup. Legal experts use this search engine to find case law, legal papers, and publications for case-related research.

CORELINESOFT

Series C in 2021
CORELINESOFT develops medical software products.

SodaGift

Venture Round in 2021
SodaGift is an international gifting service platform that simplifies cross-border gift giving. It offers a seamless user experience and supports multiple languages, enabling users to send gifts from popular brands in the US, South Korea, and Canada to recipients worldwide.

AllRe

Seed Round in 2021
AllRe is a medical record data solution based on a hospital's electronic medical records (EMR). The software enables the precise inquiry and extraction of medical data, dataset creation, research, statistical analysis, and advanced visualization of medical data. The goal of the platform is enhance the quality and value of research through the utilization of patient data.

Willog Co.

Series A in 2021
Willog is an IoT-based logistics intelligence company that provides real-time visibility across the entire supply chain through its proprietary sensor devices and platform. This enables businesses to monitor various data points such as location, temperature, humidity, and shock during transportation, helping them track assets and ensure consistent product quality. Willog’s solution helps identify potential issues in the logistics process in advance and suggests solutions to save time and reduce costs. It is applicable across various industries and empowers customers to make data-driven decisions. • Sensor Devices (Hardware) To meet the needs of various customers and transportation sectors, Willog offers a lineup of monitoring devices tailored to each logistics segment. These devices collect logistics data throughout the transport process and securely transmit it to the monitoring software. • Monitoring Solution (Software) Willog provides software optimized for logistics processes in tandem with its sensor devices. The software intuitively displays logistics condition data such as temperature, humidity, shock, and light levels collected during transport, eliminating the need for time-consuming manual tasks like post-delivery data mapping. Based on the collected data, the system analyzes shipment history to detect potential issues in advance during transportation and storage, helping to predict and minimize loss or cost. Additionally, Willog’s proprietary data analysis methodology, Willog Connected Intelligence, generates specialized analytics reports for each logistics domain—delivering insights beyond basic data logs and alerts.

S-Alpha Therapeutics

Series A in 2021
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, established in 2019. It specializes in researching and developing health applications and platform technologies that leverage digital devices for the treatment of various diseases. The company’s product pipeline includes SAT-001, an application focused on ophthalmology for eye disease treatment; SAT-002, which addresses neurological conditions; SAT-003, designed for oncology to support cancer patients in their recovery; and SAT-008, aimed at public crises to address social issues. In addition to its health applications, S-Alpha Therapeutics also develops therapeutic devices, striving to provide innovative solutions for unmet medical needs across multiple therapeutic areas, including ophthalmology, neuropsychiatry, and cancer.

Karis Bio

Series A in 2021
Karis Bio is a biotechnology company focused on developing innovative cell therapies for cardiovascular diseases. It specializes in creating cell-based treatments that utilize patented technology for generating induced pluripotent stem cells (iPSCs) and differentiating them into endothelial cells. This advanced approach aims to enhance patient recovery from cardiovascular conditions, offering new possibilities for treatment in a field that requires effective solutions. By leveraging cutting-edge stem cell technology, Karis Bio is positioned to make significant contributions to the management and treatment of cardiovascular diseases.

Proteina

Series C in 2021
Proteina develops innovative cancer diagnostic technology that precisely detects and analyzes protein interactions at the single-molecule level. This enables real-time monitoring of cancer signal pathways, predicting drug resistance and enhancing treatment efficacy.

Wavebridge

Series A in 2021
Founded in November 2018, Wavebridge is a leading digital asset company specializing in institutional investments. It offers comprehensive solutions leveraging advanced data processing and AI technology, focusing on both traditional and crypto finance.

Reebonz Korea

Series A in 2021
Reebonz Korea, Ltd is a company based in Seoul, South Korea, specializing in the import, export, wholesale, and retail of luxury products for both men and women. The company provides a wide range of items, including bags, wallets, watches, shoes, clothing, cosmetics, and fashion accessories. Reebonz operates an e-commerce marketplace that features popular luxury goods as well as pre-owned items from coveted designer brands. The platform offers customers the convenience of shopping for the latest fashion items and includes options for both buying and selling, along with personalized services.

PeopleBio

Post in 2021
PeopleBio specializes in developing diagnostic tools for protein misfolding diseases, with a focus on early detection technologies. It collaborates with global institutions to advance its Multimer Detection System technology.

Cookat

Series B in 2021
Cookat is a digital content creator specializing in food and culinary trends, focused on delivering engaging videos and unique recipes. The company operates a food blogging platform optimized for mobile users, allowing it to effectively share visually appealing food content across social media channels. By providing a space for food enthusiasts to explore innovative recipes and gourmet ideas, Cookat enhances consumer engagement and promotes the latest culinary trends. In addition to content creation, the platform facilitates the sale of wholesale items, including restaurant advertisements and home meal replacements, connecting consumers within the food market.

GI Innovation

Series C in 2021
GI Innovation, based in South Korea, specializes in bio-ventures by integrating basic science with translational innovation to develop biologics for global patients. Its strategic focus lies in immuno-oncology and inflammation/immunology diseases, leveraging the GI-SMART platform technology to efficiently optimize multi-targeting fusion protein therapeutics.

Yipscell

Series A in 2021
Yipscell is a biotech company that develops IPSC stem cell therapy to diagnose and treat incurable diseases.

Mezoo

Series A in 2021
Mezoo is a medical device manufacturing company focused on developing innovative biomedical sensor technology aimed at enhancing human health through accurate diagnoses. The company specializes in creating a small, patch-type electrocardiogram that adheres to the chest of the test subject. This device enables real-time monitoring of cardiac activity, allowing physicians to effectively manage and prevent heart disease in patients. Through its advanced technology, Mezoo contributes to improving health outcomes and advancing the field of medical diagnostics.

Gencurix

Venture Round in 2021
Founded in 2011, Gencurix is a South Korean company specializing in the development of molecular diagnostic products to support precision medicine. Its portfolio includes prognostic tests for breast cancer (GenesWell BCT) and lung cancer (GenesWell ddEGFR Mutation Test), as well as companion diagnostics for lung cancer.

iN Therapeutics

Series A in 2021
iN Therapeutics is a biotechnology company focused on developing novel therapies for patients with intractable neurological disorders. Its drug development platform concentrates on Nav1.7 non-narcotic analgesics, hearing loss treatments, and brain disease therapeutics, aiming to provide pharmaceutical and biotech industries access to innovative central nervous system disease drugs.

People & Technology

Series A in 2021
Founded in 2013, People & Technology specializes in AI-driven indoor geolocation solutions. Its platform, IndoorPlus+, serves diverse sectors like healthcare, manufacturing, defense, smart cities, and public services. With over 100 corporate clients, the company improves productivity, reduces risks, and optimizes procurement through solutions for employee safety, asset tracking, security management, flow optimization, and process efficiency.

Cenyx Biotech

Series A in 2021
Cenyx Biotech develops diagnostic and therapeutic nano compounds based on nanozymes and nanoparticles. It is advancing a nano-biotech platform to transform healthcare by engineering agents that simultaneously scavenge reactive oxygen species, including superoxide, hydrogen peroxide, and hydroxyl radicals. This approach aims to reduce excessive inflammatory responses in the early stage of subarachnoid hemorrhage, potentially improving patient outcomes.

VEStellaLab

Series A in 2021
VEStellaLab is a provider of advanced AI-based navigation solutions focused on enhancing parking experiences for drivers and autonomous vehicles. The company offers innovative indoor navigation services, including WatchMile, which assists drivers in locating optimal parking spots by using cutting-edge indoor positioning technology and vision AI recognition. This system not only identifies available parking spaces in real time but also guides users to their selected locations, effectively addressing common challenges such as congestion and inefficient parking. By leveraging proprietary technologies that convert CAD files into lighter digital maps and employing precise positioning algorithms, VEStellaLab aims to streamline the parking process, providing significant value in smart city initiatives and the evolving landscape of autonomous transportation.

MitoImmune Therapeutics

Series B in 2021
MitoImmune Therapeutics is a biotechnology company focused on drug research and development aimed at treating mitochondrial dysfunction and various cellular disorders. The company specializes in creating therapies for diseases related to mitochondrial dysfunction, including necrotic and inflammatory conditions. By developing targeted treatments, MitoImmune Therapeutics aims to enhance the quality of life for patients suffering from these complex health issues.

Biobab AiBIO

Series A in 2021
Biobab AiBIO is a biotechnology company that develops drugs using artificial intelligence and a proprietary bio-space voyager technology to accelerate drug discovery, with a focus on rare and intractable diseases. The company leverages cryogenic electron microscopy to determine the three-dimensional structure of target proteins, addressing limitations of traditional X-ray crystallography, enabling the development of drugs for innovative targets.

MBD

Series B in 2021
MBD is a biotechnology company that specializes in 3D cell culture platforms.

AbTis

Series B in 2021
AbTis is a biotechnology company specializing in antibody-drug conjugation technology and the solubilization of drugs. Its innovative technology aims to improve the safety and efficacy of existing antibody-drug conjugates without the need for mutation or engineering of the antibodies themselves. This approach allows for the application of the technology to a wide range of antibodies, including native, commercial, and novel antibodies under development. By enhancing access to antibody-drug conjugates, AbTis supports medical professionals in their efforts to develop effective therapeutic solutions.

S-Alpha Therapeutics

Seed Round in 2020
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, established in 2019. It specializes in researching and developing health applications and platform technologies that leverage digital devices for the treatment of various diseases. The company’s product pipeline includes SAT-001, an application focused on ophthalmology for eye disease treatment; SAT-002, which addresses neurological conditions; SAT-003, designed for oncology to support cancer patients in their recovery; and SAT-008, aimed at public crises to address social issues. In addition to its health applications, S-Alpha Therapeutics also develops therapeutic devices, striving to provide innovative solutions for unmet medical needs across multiple therapeutic areas, including ophthalmology, neuropsychiatry, and cancer.

Olix Pharmaceuticals

Post in 2020
OliX Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Suwon, South Korea, dedicated to developing RNA interference (RNAi) therapeutics targeting various dermal, ophthalmic, and pulmonary diseases. The company’s product pipeline includes OLX101 for skin scarring, OLX102 for skin whitening, OLX103 for atopic dermatitis, OLX104 for hair loss, OLX105 for anti-wrinkle treatments, and OLX106 for diabetic foot ulcers. Additionally, it is developing OLX301 for age-related macular degeneration, OLX304 for retinitis pigmentosa, OLX201 for lung fibrosis, OLX202 for asthma, OLX203 for influenza, OLX401 for neuropathic pain, OLX701 for liver fibrosis, and OLX701 for cancer immunotherapy. The company has also entered into a collaboration agreement with Théa to advance SiRNA therapeutics for ophthalmic conditions. Founded in 2010, OliX Pharmaceuticals leverages its proprietary RNAi technology to regulate the expression of genes associated with various diseases.

LBox

Seed Round in 2020
LBox develops a digital platform that simplifies legal information lookup. Legal experts use this search engine to find case law, legal papers, and publications for case-related research.

CORELINESOFT

Series B in 2020
CORELINESOFT develops medical software products.

J2H Biotech

Series C in 2020
J2H Biotech is a bio-venture company dedicated to the development of small-molecule drugs aimed at treating rare and intractable diseases. The company specializes in creating synthetic medications that enhance oral absorption rates and employs patented systems to facilitate the availability of generic drugs for conditions such as rare diseases, infectious diseases, and liver diseases. By focusing on these innovative approaches, J2H Biotech seeks to provide healthcare professionals with differentiated therapeutic options that can improve patient outcomes and contribute to overall public health.

Trenbe

Series B in 2020
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Founded in 2016, Trenbe focuses on footwear products while offering a diverse range of related fashion items to cater to its customers' needs.

5minlab

Series A in 2020
5minlab is a South Korean game development company established in 2013, headquartered in Seoul. It specializes in creating PC/mobile games, with a portfolio comprising five PC/mobile titles, three VR games, and twenty-four hyper-casual games. The company's expertise has grown through various outsourcing projects, leading to the development of 'Smash Legends', a global PvP game launched in 2018. With seventy experts on board, including industry veterans like the art director of 'Dragon Nest' and 'Phantom Chaser', 5minlab aims to release its next game by 2024, aspiring to create global intellectual property in gaming.

Autotelic Bio

Series A in 2020
Autotelic Bio is a biotechnology company dedicated to researching and developing innovative anti-cancer drugs. Its primary focus lies in creating targeted therapies using antisense oligonucleotide technology, aiming to enhance efficacy and safety compared to traditional cancer treatments.

Laundrygo

Series B in 2020
Laundrygo is an on-demand laundry service that offers subscription-based laundry cleaning solutions. The company focuses on delivering a convenient and efficient alternative to traditional laundry services by ensuring that customers receive their cleaned laundry within one day. By providing this rapid turnaround at a lower cost than conventional laundry shops, Laundrygo aims to enhance the customer experience and eliminate the hassle often associated with laundry tasks.

Kukka

Series A in 2020
Kukka, Inc. is a Seoul-based company that specializes in providing a variety of flower-related services, including flower subscription, bouquet delivery, and custom floral design. Established in 2014, Kukka aims to promote the enjoyment of flowers in everyday life, inspired by Finnish culture. Its offerings cater to both individual and corporate clients, featuring corporate event support flowers, promotional flower boxes, and floral decorations. The company also provides same-day delivery and organizes flower art classes, enhancing the floral experience for its customers. Through its retail stores and online platform, Kukka facilitates easy access to fresh flowers and related accessories.

AUTOTAC Bio

Series B in 2020
AUTOTAC Bio is a biopharmaceutical company specializing in the development of protein target decomposition drugs for human therapeutics. Its primary focus lies in creating treatments for rare and incurable diseases, including viral infections and cancers, leveraging autophagy-based technology.

Organoid Sciences

Series A in 2020
Organoid Sciences is a biotechnology company founded in 2018 and located in Seongnam-si, South Korea. The company specializes in developing organoid-based therapies using its proprietary Keo cannabinoid technology to address various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, aiming to advance treatment options through innovative approaches.

Macaron M

Series A in 2020
Macaron M is a mobile application that specializes in providing taxi services, focusing on scheduled car reservations. The platform allows users to reserve vehicles through a straightforward calling system as well as through the app, which offers a selection of various vehicle options. Macaron M aims to enhance the travel experience by simplifying the payment process and offering discounts, making it easier for customers to plan their journeys in advance.

Seer

Series D in 2019
Seer, Inc. is a life sciences company that specializes in nanoparticle technology solutions aimed at advancing proteomics research. The company offers Proteograph, an integrated system that includes consumables, automation instrumentation, and proprietary software for conducting proteomics analysis. Seer's products are designed for research applications, targeting academic institutions, life sciences laboratories, and biopharmaceutical companies for non-diagnostic and non-clinical uses. Additionally, Seer is focused on developing a health data platform that enhances early detection of chronic diseases by capturing and translating molecular insights from the proteome, thereby enabling healthcare professionals to identify conditions such as cancer and neurological disorders more accurately and rapidly. Founded in 2017 and headquartered in Redwood City, California, Seer was previously known as Seer Biosciences, Inc. before rebranding in July 2018.

Sparkplus

Series B in 2019
SparkPlus is a South Korean company founded in 2016 that specializes in designing and managing real estate contracts, interior design, construction, and furniture arrangements for office spaces. The company operates coworking spaces aimed at businesses facing challenges with their office environments. By providing comprehensive solutions to corporate office issues, SparkPlus enables clients to focus on their core activities without the distractions of managing office-related problems. The firm's services are tailored to create functional and efficient workspaces that enhance productivity and business growth.

Adapt

Series A in 2019
Adapt is a brand and content marketing platform that focuses on D2C concept, customer feedback and constant analysis.

FamePick

Series A in 2019
FamePick Inc. is a subscription-based internet platform founded in 2016 and headquartered in Sunnyvale, California. The company focuses on the advertising and marketing industry by enabling users to find, secure, and launch celebrity-driven marketing campaigns across social media. FamePick provides seasoned creators and influencers with essential tools to manage their personal brands effectively. The platform offers automated media kits that include audience reach, detailed demographics, and recent brand deals, helping creators assess their market value. Additionally, FamePick facilitates connections between established creators and like-minded partners, supporting them in building stronger relationships and expanding their reach into other platforms and paid media.

Leferi

Series B in 2019
Leferi is a beauty influencer business group that fosters influencers, marketing, and commerce.

Fresh Easy

Series C in 2019
Fresh Easy is a distributor of meal kits.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.